AstraZeneca has resumed trials of its Covid vaccine. They were suspended due to the illness of one of the volunteers

The Swedish-British company AstraZeneca said that UK trials of a coronavirus vaccine developed jointly with the University of Oxford have resumed.

AstraZeneca stressed that the trials have begun again after UK regulators confirmed the safety of the drug by conducting an investigation after one of the trial participants fell ill.

• AstraZeneca's vaccine trials were suspended worldwide on September 6 after one of the volunteers was diagnosed with transverse myelitis. This is an inflammation of the spinal cord, which is often caused by an infection; AstraZeneca did not rule out that the vaccine could be the cause of the disease.
• AstraZeneca's coronavirus vaccine is one of several in the world that has made it to phase three, a massive study in thousands of volunteers. Others include vaccines from Moderna, Pfizer/BioNTech and companies from China, as well as Russia's Sputnik V.

After publication, the description of the disease was corrected for a more correct one.